BP-C1 in the treatment of patients with stage IV breast cancer: A randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
© 2014 Larsen et al. The aims were to compare the efficacy and tolerability of a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride (BP-C1) versus placebo and to investigate the long-term tolerability of BP-C1 in the treatment of patients with metastatic breast cance...
Saved in:
Main Authors: | Stig Larsen, Kritiya Butthongkomvong, Alexey Manikhas, Ekaterina Trishkina, Elena Poddubuskaya, Marina Matrosova, Vichien Srimuninnimit, Steen Lindkær-Jensen |
---|---|
Other Authors: | Norwegian University of Life Science |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34161 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Efficacy and tolerability of BP-C1 in metastatic breast cancer: A Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study
by: Kritiya Butthongkomvong, et al.
Published: (2020) -
Benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in the treatment of stage IV breast cancer patients
by: Sagita Dewi, et al.
Published: (2018) -
Comparison of midazolam, diazepam and placebo in the treatment of insomnia
by: Kok, L.P., et al.
Published: (2012) -
Curcuma aeruginosa, a novel botanically derived 5a-reductase inhibitor in the treatment of male-pattern baldness: A multicenter, randomized, double-blind, placebo-controlled study
by: Ganniga Pumthong, et al.
Published: (2018) -
Curcuma aeruginosa, a novel botanically derived 5a-reductase inhibitor in the treatment of male-pattern baldness: A multicenter, randomized, double-blind, placebo-controlled study
by: Pumthong G., et al.
Published: (2017)